The Lancet Oncology: Tackling the global shortfall in radiotherapy could save millions of lives and boost the economy of poorer countries

Millions of people are dying from potentially treatable cancers like breast and prostate because of a chronic underinvestment in radiotherapy resources, according to a major new Commission on access to radiotherapy, published in The Lancet Oncology, and being presented at the 2015 European Cancer Congress in Vienna, Austria.